ALT A new obesity treatment being developed by Altimmune met goals for weight loss in a mid-stage clinical trial, but the data showed it doesn’t have a leg up on other popular drugs on the market. https://www.statnews.com/2023/03/21/obesity-drug-altimmune-pemvidutide-early-data/